Select Medical Holdings (SEM) Receivables (2018 - 2026)

Select Medical Holdings has disclosed Receivables across 9 years of filings, most recently posting $949.5 million for Q1 2026.

• In Q1 2026, Receivables rose 4.55% year-over-year to $949.5 million; the TTM figure through Mar 2026 stood at $949.5 million (up 4.55% YoY), while the FY2025 annual figure was $864.2 million, up 5.21% from the prior year.
• Receivables improved to $949.5 million in Q1 2026, from $864.2 million in the prior quarter.
• Over the last five years, Receivables for SEM reached as high as $1.1 billion in Q1 2024 and fell as low as $724.1 million in Q4 2023.
• The 5-year median for Receivables is $941.4 million (2022), against an average of $936.0 million.
• Annual changes were most pronounced in 2023 — Receivables declined 24.38% — and 2024, when it increased 13.79%.
• A 5-year view of Receivables shows it stood at $957.6 million in 2022, then decreased by 24.38% to $724.1 million in 2023, then rose by 13.43% to $821.4 million in 2024, then gained by 5.21% to $864.2 million in 2025, then advanced by 9.87% to $949.5 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $949.5 million, $864.2 million, and $825.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.